Source: MSF Access Campaign 15 Jan 2014 The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) began introducing hepatitis C (HCV) treatment to several patients in India in 2013, and is in the process of scaling up treatment … Continue reading
Source: Economic Times 30 Oct 2014 NEW DELHI: Cipla, India’s fifthlargest drugmaker by revenue, has asked the government to revoke five patents that Novartis holds on respiratory drug Onbrez and launched its generic version of indacaterol at a fifth of … Continue reading
Source: PMLive Compulsory licensing and other legal concerns for pharma in emerging markets For as long as pharma and biotech companies have contemplated doing business in BRIC, there have been questions about intellectual property (IP) risk.
Posted in BRICS, Compulsory Licensing, IP Rights, Novartis Case, Patents
Tagged BRIC, China, Compulsory license, Doha Declaration, India, Intellectual property, Patent, United States
Source: IAS 1 July 2013 To Francoise Barré-Sinoussi, President of the International AIDS Society The Malaysian Government will be hosting the next round of negotiations for Trans-Pacific Partnership (TPP) free trade agreement in Kota Kinabalu, from 15 to 25 July. The … Continue reading
Source: Aljazeera Medical corporations seek tools to protect their profits despite harmful effects on public health. The Trans-Pacific Partnership (TPP) is a deal that is being secretly negotiated by the White House, with the help of more than 600 corporate advisers and … Continue reading